Celldex Therapeutics, Inc. (CLDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
3.49+0.02 (+0.58%)
At close: 4:00 PM EDT
People also watch:
ACADCLVSSGENSRPTARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.52
Prev Close3.47
Bid3.40 x 2000
Ask3.65 x 700
Day's Range3.39 - 3.52
52wk Range2.96 - 18.62
1y Target EstN/A
Market Cap350.91M
P/E Ratio (ttm)-2.62
Beta2.37
Volume1,898,796
Avg Vol (3m)2,365,571
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • 3 Reasons Celldex Therapeutics, Inc. Stock Could Fall
    Motley Fool8 hours ago

    3 Reasons Celldex Therapeutics, Inc. Stock Could Fall

    Could the beleaguered biotech's stock decline even more?

  • Capital Cube8 days ago

    ETF’s with exposure to Celldex Therapeutics, Inc. : August 18, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Celldex Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to CLDX-US. Comparing the performance and risk of Celldex Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
    Capital Cube11 days ago

    Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016

    Categories: Yahoo Finance Get free summary analysis Celldex Therapeutics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Celldex Therapeutics, Inc. – Seattle Genetics, Inc., Emergent BioSolutions Inc., Agenus Inc., GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Vical Incorporated, Bristol-Myers Squibb Company, Pfizer Inc. and CytRx Corporation ... Read more (Read more...)